On National Previvor Day, learn what it means to carry an inherited gene change like BRCA1 or BRCA2, and the screening and surgery options that lower risk.
News|Articles|October 1, 2026
5 Years of Breast Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients
Author(s)Quincy Attobrah
Fact checked by: CURE staff
Breast cancer treatment has changed dramatically since 2021. Here are the key FDA approvals, year by year, and what they mean for patients.
Advertisement
Advertisement
Breast cancer treatment has changed more in five years than many people realize. If you or someone you love is living with it, it helps to know not just that things have improved, but how, because the pattern behind these changes is the best clue we have for what's coming next.
Related to this article
Long-term results presented at ASTRO 2026 show that a shorter radiation schedule after mastectomy controls high-risk breast cancer as well as the standard five-week course, without more long-term side effects.
FDA fast-tracks review of elinzanetant for hot flashes linked to breast cancer treatment. Here’s what the trial found and what patients should know.
Sue Weldon, a 22-year breast cancer survivor and Unite for HER founder, explains how integrative therapies helped her heal after chemotherapy.
Heather Curley discusses her leptomeningeal disease diagnosis, joining an experimental vaccine trial and the milestones she has been able to share with her daughter.
A phase 3 trial presented at ASTRO 2026 found that giving focused radiation in three to five sessions, instead of one, lowered the chance of cancer returning at the surgery site, and patients lived longer.
A phase 3 trial found proton therapy did not help people with advanced liver cancer live longer than standard photon radiation therapy.
A breast surgeon explains how rebuilding the breast with a person's own tissue and new tools may boost satisfaction and cut repeat surgery.
Advertisement
Advertisement